Full Length Research Paper
References
|
Batista, MC, Carvalho CMB, Magalhães NSS (2007). Lipossomas e suas aplicações terapêuticas: Estado da arte. Rev. Bras. Cienc. Farm. 43 (2):167-179. |
|
|
Batistela AM, Chorilli M, Leonardi RG (2007). Approach to the process knowledge of skin aging among different ethnics. Rev. Bras. Farm. 88 (2): 59-62. |
|
|
Blanes-Mira C, Clemente J, Jodas G, Gil A, Fernandez-Ballester G, Ponsati B, Gutierrez L, Perz-Paya E, Ferrer-Montiel, A (2002). A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int. J. Cosmetic Sci. 24: 303-310. |
|
|
Bouchemal K, Briançon S, Perrier E, Fessi H (2004). Nanoemulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimization. Int. J. Pharm. Nanotech. 280: 241-251. |
|
|
Brigger I, Dubernet C, Couvreur P (2002). Nanoparticles in cancer therapy and diagnosis. Adv. Drug. Deliv. Rev. 54 (5): 631-651. |
|
|
Bruschi M (2010). Formulações tópicas contendo nanocápsulas de adapaleno: avaliação da estabilidade e permeação cutânea. Santa Maria,RS. |
|
|
Buck DW, Alam M, Kim JYS (2009). Injectable fillers for facial rejuvenation: A review. J. Plast. Reconstr. Aesthet. Surg. 62(1):11-18. |
|
|
Couvreur P, Barratt G, Fattal E, Legrand P, Vauthier C (2002). Nanocapsule technology: A review. Crit Rev.Ther. Drug Carrier Syst.19:99-134. |
|
|
Esteves, AF (2011). Lipossomas como modelos biomoleculares. Correlação entre coeficientes de partição (lipossoma/água e octanol) e actividade de compostos farmacologicamente activos. Fernando Pessoa University, Porto. |
|
|
Feczkó T, Tóth J, Gyenis J (2008). Comparison of the preparation of PLGA-BSA nano and microparticles by PVA, poloxamer and PVP. Colloids and Surfaces A: Phys. Eng. Aspects. 319 (1):188-195. |
|
|
Gaumet M, Vargas A, Gurny R, Delie F (2008). Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur. J. Pharm. Biopharm. 69:1-9. |
|
|
Gorouhi F, Maibach H (2009). Role of topical peptides in preventing or treating aged skin. Int. J. Cosmetic Sci. 31(5):327-345. |
|
|
Jiao Y, Ubrich N, Marchand-Avier M, Vigneron C, Hoffman M, Lecompte T, Maincent P (2002). In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits. Circulation.105:230-235. |
|
|
Khavkin JA, Ellis F (2011). Aging skin: histology, physiology, and the patology. Facial Plast. Surg. Clin. North Am. 19:229-234. |
|
|
Kiba T (2004). Relationships between the autonomic nervous system and the Pancreas including regulation of regeneration and Apoptosis.Pancreas. 29(2):1-8. |
|
|
Kulkamp CI, Paese K, Guterrez SS, Pohlman AR (2009). Stabiliazation of lipoic acid by encapsulation in polymeric nanocapsules designed for cutaneous administration. Quím. Nova. 32(8):2078-2084. |
|
|
Lamprecht, A., Ubrich N, Yamamoto H, Schafer U, Takeuchi H, Lehr CM, Maincent P, Kawashima Y (2001). Design of rolipram-loaded nanoparticles: comparison of two preparation methods. J Control Release. 71(3):297-306. |
|
|
Lasic DD (1998). Novel applications of liposomes.Trends Biotechnol. 16 (7):307-321. |
|
|
Lima FF, Andrade TC (2012). Um sistema simples para produção de microesferas de quitosana. Quím Nova. 15:1-6. |
|
|
Mahajan ST, Brubaker I (2007). Botulinum toxin: from life-threatening disease to novel medical therapy. Am. J. Obstet. Gynecol. 196 (1):7-15. |
|
|
Müller CR, Schaffazick SR, Pohlmann AR, Freitas LL, Silveira NP, Dalla- Costa T, Guterres, SS (2001). Spray-dried diclofenac-loaded poly(e -caprolactone) nanocapsules and nanospheres: Preparation and physicochemical characterization. Pharmazie. 56:864-867. |
|
|
Paese, K (2008). Desenvolvimento tecnológico, estudo de fotoestabilidade e avaliação da permeação cutânea in vitro da benzofenona-3 a partir das nanocápsulas poliméricas incorporadas em diferentes veículos semi-sólidos. Curso de Pós-Graduação.UFRGS. |
|
|
Perez MH, Zinutti C, Lamprecht A, Ubrich N, Astier A, Hoffman M, Bodmeier R, Maincent P(2000). The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug. J. Control Release. 65(3):429-438. |
|
|
Pimentel F L, Júnior JTA, Mosqueira CV, Magalhaes-Santos SN (2007). Nanotecnologia farmacêutica aplicada ao tratamento da malária. Braz. J. Pharm. Sci. 43(4). |
|
|
Poletto SF, Jager E, Cruz I, Pohlmann AR, Guterres SS (2008). The effect of polymeric wall on the permeability of drug-loaded nanocapsules. Mater Sci Eng. 28:472-478. |
|
|
Schaffazick RS, Guterres SS, Freitas LL, Pohlmann AR (2003). Caracterização e estabilidade físico-química de sistemas poliméricos nanoparticulados para administração de fármacos.Quim. Nova. 26(5):726-737. |
|
|
Schaffazick SR, Guterres SS, Pohlmann RA, Freitas CL (2003). Caracterização e estabilidade físico-química de sistemas poliméricos nanoparticulados para administração de fármacos. Quím. Nova. 26(5):726-737. |
|
|
Sengodan T, Sunil B, Vaishali R, Chandra RJ (2009). Formulation and Evaluation of maltodextrin based proniosomes loaded with Indomethacin. Int J Pharm Tech Res. 1(3):517-523. |
|
|
Singh J, Pandit S, Bramwell VW, Alpar HO (2006). Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems. Methods 38:96-105. |
|
|
Soppimath KS, Aminabhvi TM, Kulkarni AR, Rudzinski WE (2001). Biodegradable polymeric nanoparticles as drug delivery devices. J. Control Release 70(1-2):1-20. |
|
|
Sposito MMM (2004). Toxina botulínica tipo A - propriedades farmacológicas e uso clínico. Acta Fisiátr. 1: 7-44. |
|
|
Tyagi P, Wu PC, Chancellor M, Yoshimura N, Huang I (2006).Recent advances in intravesical drug/gene delivery. Mol. Pharmaceut. 3(4):369-379. |
|
|
Verger ML, Fluckiger I, Kim Y, Hoffman M, Maincent P(1998). Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur. J. Pharm. Biopharm. 46(2):137-143. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
